Pathophysiological Mechanisms in Sclerosing Skin Diseases
Sclerosing skin diseases represent a large number of distinct disease entities, which include systemic sclerosis, localized scleroderma, and scleredema adultorum. These pathologies have a common clinical appearance and share histological features. However, the specific interplay between cytokines an...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-08-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fmed.2017.00120/full |
id |
doaj-4f054e7ce003470389401d2cd808686c |
---|---|
record_format |
Article |
spelling |
doaj-4f054e7ce003470389401d2cd808686c2020-11-24T22:56:46ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2017-08-01410.3389/fmed.2017.00120271491Pathophysiological Mechanisms in Sclerosing Skin DiseasesBeate Eckes0Fang Wang1Pia Moinzadeh2Nicolas Hunzelmann3Thomas Krieg4Thomas Krieg5Thomas Krieg6Department of Dermatology, University of Cologne, Cologne, GermanyDepartment of Dermatology, University of Cologne, Cologne, GermanyDepartment of Dermatology, University of Cologne, Cologne, GermanyDepartment of Dermatology, University of Cologne, Cologne, GermanyDepartment of Dermatology, University of Cologne, Cologne, GermanyCenter for Molecular Medicine (CMMC), Cologne, GermanyCluster of Excellence in Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, GermanySclerosing skin diseases represent a large number of distinct disease entities, which include systemic sclerosis, localized scleroderma, and scleredema adultorum. These pathologies have a common clinical appearance and share histological features. However, the specific interplay between cytokines and growth factors, which activate different mesenchymal cell populations and production of different extracellular matrix components, determines the biomechanical properties of the skin and the clinical features of each disease. A better understanding of the mechanisms underlying these events is prerequisite for developing novel targeted therapeutic approaches.http://journal.frontiersin.org/article/10.3389/fmed.2017.00120/fullsystemic sclerosisscleromyxedemascleredemastiff skin syndromenephrogenic systemic fibrosisextracellular matrix |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Beate Eckes Fang Wang Pia Moinzadeh Nicolas Hunzelmann Thomas Krieg Thomas Krieg Thomas Krieg |
spellingShingle |
Beate Eckes Fang Wang Pia Moinzadeh Nicolas Hunzelmann Thomas Krieg Thomas Krieg Thomas Krieg Pathophysiological Mechanisms in Sclerosing Skin Diseases Frontiers in Medicine systemic sclerosis scleromyxedema scleredema stiff skin syndrome nephrogenic systemic fibrosis extracellular matrix |
author_facet |
Beate Eckes Fang Wang Pia Moinzadeh Nicolas Hunzelmann Thomas Krieg Thomas Krieg Thomas Krieg |
author_sort |
Beate Eckes |
title |
Pathophysiological Mechanisms in Sclerosing Skin Diseases |
title_short |
Pathophysiological Mechanisms in Sclerosing Skin Diseases |
title_full |
Pathophysiological Mechanisms in Sclerosing Skin Diseases |
title_fullStr |
Pathophysiological Mechanisms in Sclerosing Skin Diseases |
title_full_unstemmed |
Pathophysiological Mechanisms in Sclerosing Skin Diseases |
title_sort |
pathophysiological mechanisms in sclerosing skin diseases |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Medicine |
issn |
2296-858X |
publishDate |
2017-08-01 |
description |
Sclerosing skin diseases represent a large number of distinct disease entities, which include systemic sclerosis, localized scleroderma, and scleredema adultorum. These pathologies have a common clinical appearance and share histological features. However, the specific interplay between cytokines and growth factors, which activate different mesenchymal cell populations and production of different extracellular matrix components, determines the biomechanical properties of the skin and the clinical features of each disease. A better understanding of the mechanisms underlying these events is prerequisite for developing novel targeted therapeutic approaches. |
topic |
systemic sclerosis scleromyxedema scleredema stiff skin syndrome nephrogenic systemic fibrosis extracellular matrix |
url |
http://journal.frontiersin.org/article/10.3389/fmed.2017.00120/full |
work_keys_str_mv |
AT beateeckes pathophysiologicalmechanismsinsclerosingskindiseases AT fangwang pathophysiologicalmechanismsinsclerosingskindiseases AT piamoinzadeh pathophysiologicalmechanismsinsclerosingskindiseases AT nicolashunzelmann pathophysiologicalmechanismsinsclerosingskindiseases AT thomaskrieg pathophysiologicalmechanismsinsclerosingskindiseases AT thomaskrieg pathophysiologicalmechanismsinsclerosingskindiseases AT thomaskrieg pathophysiologicalmechanismsinsclerosingskindiseases |
_version_ |
1725653482038362112 |